Psychological effects of personalized dementia risk disclosure: The Barcelonaβeta Dementia Prevention Research Clinic study

Abstract Background Approximately 35‐40% of new patients at memory clinics are cognitively intact individuals concerned about their dementia risk. The demand for personalized risk profiling and preventive strategies for those at higher dementia risk is in need of innovative infrastructures. However, disclosing dementia risk estimates raises concerns about potential negative emotional impacts. To address this challenge, the Barcelonaβeta Dementia Prevention Research Clinic, was established to evaluate the risks and benefits of novel prevention infrastructures and the potential impact of dementia risk disclosure. Here we focus on the psychological effects of personalized dementia risk disclosure on cognitively unimpaired individuals with subjective cognitive decline (SCD). Method Participants aged 60‐80 with cognitive complaints were pre‐selected using web‐based algorithms. Eligible participants were invited to an in‐person visit and a clinical diagnosis was established after neuropsychological, blood tests and magnetic resonance imaging assessments. Dementia risk over 5 years (%risk) was calculated and disclosed with personalized prevention plans. Impact on depression (CES‐D), anxiety (STAI), and test‐related distress (IGT‐AD) was assessed up to 12 months post‐disclosure. SCD participants were categorized into “high dementia risk” (HDR, %risk>10.8) and “low dementia risk” (LDR, %risk<3.6) groups, based on previous epidemiological evidence. Wilcoxon rank‐sum tests and Spearman’s rank correlation analyzed between‐group differences and correlations at different time points. Result The percentage of 5‐years dementia risk was disclosed to 192 participants with SCD. Test‐related distress (IGT‐AD) was consistently higher in HDR (N = 25) vs. LDR (N = 55), while CES‐D and STAI showed no significant differences between groups (Table 1, Figure 1). Similar results were observed in correlation analyses for the entire sample (Table 2). Median CES‐D and STAI‐S values remained below clinically relevant cutoffs for depression and anxiety across all visits. Conclusion Disclosure of dementia risk heightened test‐related distress but did not manifest clinically relevant negative effects in anxiety and depression scales. The potential impact of this psychological response on promoting engagement in preventive behaviors warrants further exploration.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-01
DOI
https://doi.org/10.1002/alz.092351
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Psychological effects of personalized dementia risk disclosure: The Barcelonaβeta Dementia Prevention Research Clinic study

Karine Fauria, Gonzalo Sánchez‐Benavides, José Luís Molinuevo, Juan Domingo Gispert et al.
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

Psychological effects of personalized dementia risk disclosure: The Barcelonaβeta Dementia Prevention Research Clinic study

Karine Fauria, Gonzalo Sánchez‐Benavides, José Luís Molinuevo, Juan Domingo Gispert, Oriol Grau‐Rivera, Marc Suárez‐Calvet, Carolina Minguillón
article en

Abstract

Abstract Background Approximately 35‐40% of new patients at memory clinics are cognitively intact individuals concerned about their dementia risk. The demand for personalized risk profiling and preventive strategies for those at higher dementia risk is in need of innovative infrastructures. However, disclosing dementia risk estimates raises concerns about potential negative emotional impacts. To address this challenge, the Barcelonaβeta Dementia Prevention Research Clinic, was established to evaluate the risks and benefits of novel prevention infrastructures and the potential impact of dementia risk disclosure. Here we focus on the psychological effects of personalized dementia risk disclosure on cognitively unimpaired individuals with subjective cognitive decline (SCD). Method Participants aged 60‐80 with cognitive complaints were pre‐selected using web‐based algorithms. Eligible participants were invited to an in‐person visit and a clinical diagnosis was established after neuropsychological, blood tests and magnetic resonance imaging assessments. Dementia risk over 5 years (%risk) was calculated and disclosed with personalized prevention plans. Impact on depression (CES‐D), anxiety (STAI), and test‐related distress (IGT‐AD) was assessed up to 12 months post‐disclosure. SCD participants were categorized into “high dementia risk” (HDR, %risk>10.8) and “low dementia risk” (LDR, %risk<3.6) groups, based on previous epidemiological evidence. Wilcoxon rank‐sum tests and Spearman’s rank correlation analyzed between‐group differences and correlations at different time points. Result The percentage of 5‐years dementia risk was disclosed to 192 participants with SCD. Test‐related distress (IGT‐AD) was consistently higher in HDR (N = 25) vs. LDR (N = 55), while CES‐D and STAI showed no significant differences between groups (Table 1, Figure 1). Similar results were observed in correlation analyses for the entire sample (Table 2). Median CES‐D and STAI‐S values remained below clinically relevant cutoffs for depression and anxiety across all visits. Conclusion Disclosure of dementia risk heightened test‐related distress but did not manifest clinically relevant negative effects in anxiety and depression scales. The potential impact of this psychological response on promoting engagement in preventive behaviors warrants further exploration.

Alzheimer s & DementiaVol. 20(S7)
Lundbeck (Denmark) (DK), Instituto de Salud Carlos III (ES), Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (ES), Pasqual Maragall Foundation (ES), Barcelonaβeta Brain Research Center (ES), Hospital Del Mar (ES), Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (ES)
Openalex Percentile: Top 65%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.